Skip to content
10-Q

Quarterly Report

PLANDAI BIOTECHNOLOGY, INC.

0001262463-16-001012

← back to feed
Filed
Aug 17, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Aug 15, 2016 186.53M sh
Capex Q3 2016 · Mar 31, 2016 $11.38K
Capex Q3 2016 · Mar 31, 2015 $752.08K
Operating Cash Flow Q3 2016 · Mar 31, 2016 −$828.81K
Operating Cash Flow restated Q3 2016 · Mar 31, 2015 −$1.12M
Cash And Equivalents Q3 2016 · Mar 31, 2016 $7.96K
Cash And Equivalents Q3 2016 · Jun 30, 2015 $33.62K
Cash And Equivalents Q3 2016 · Mar 31, 2015 $127.99K
Cash And Equivalents Q3 2016 · Jun 30, 2014 $156.57K
Stockholders Equity Q3 2016 · Mar 31, 2016 −$8.37M
Stockholders Equity Q3 2016 · Jun 30, 2015 −$6.5M
Current Liabilities Q3 2016 · Mar 31, 2016 $15.44M
Current Liabilities Q3 2016 · Jun 30, 2015 $15.15M
Total Liabilities Q3 2016 · Mar 31, 2016 $17.07M
Total Liabilities Q3 2016 · Jun 30, 2015 $16.82M
Current Assets Q3 2016 · Mar 31, 2016 $176.35K
Current Assets Q3 2016 · Jun 30, 2015 $418.16K
Total Assets Q3 2016 · Mar 31, 2016 $6.63M
Total Assets Q3 2016 · Jun 30, 2015 $8.5M
Sga Expense Q3 2016 · Mar 31, 2016 $193.4K
Sga Expense Q3 2016 · Mar 31, 2016 $411.19K
Sga Expense restated Q3 2016 · Mar 31, 2015 $514.83K
Sga Expense restated Q3 2016 · Mar 31, 2015 $802.15K
Net Income Q3 2016 · Mar 31, 2016 −$1.09M
Net Income Q3 2016 · Mar 31, 2016 −$3.02M
Net Income restated Q3 2016 · Mar 31, 2015 −$6.27M
Net Income Q3 2016 · Mar 31, 2015 −$8.15M
Operating Income Q3 2016 · Mar 31, 2016 −$724.9K
Operating Income Q3 2016 · Mar 31, 2016 −$2.29M
Operating Income restated Q3 2016 · Mar 31, 2015 −$5.99M
Operating Income Q3 2016 · Mar 31, 2015 −$8.37M
Revenue Q3 2016 · Mar 31, 2016 $100.3K
Revenue Q3 2016 · Mar 31, 2016 $197.8K
Revenue Q3 2016 · Mar 31, 2015 $21.74K
Revenue Q3 2016 · Mar 31, 2015 $64.02K